India’s drug regulator warns on Abbott’s bioresorbable stentsPost published:August 9, 2017Post category:Industry NewsThe Drug Controller General of India’s (DCGI) warning pertains to bioresorbable stents used in blood vessels that are 2.5mm or narrower Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostDilip Shanghvi’s oil firm may buy GSPC’s Hazira field Next PostBoeing eyes India tie-ups for drones, digital technology You Might Also Like Video: Hybrid FDM/Inkjet Printer – Part Marking, Quick Release Supports and More August 7, 2018 ITR filing: Income tax offices to remain open till midnight on Saturday August 4, 2017 Micro-Epsilon helps Donfabs & Consillia enhance inspection process June 5, 2019